Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
362
NCT00103974
Immunotherapy With BHT-3009 Alone or Combined With Atorvastatin in Patients With Multiple Sclerosis
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 31, 2004
Completion: Mar 31, 2007
NCT00382629
BHT-3009 Immunotherapy in Relapsing Remitting Multiple Sclerosis
Phase: Phase 2
Start: Feb 28, 2006
Completion: Jun 30, 2007
NCT00453375
Phase 1 Study of BHT-3021 in Subjects With Type 1 Diabetes Mellitus
Start: Oct 31, 2006
Completion: May 31, 2011